CellWell record HH-119542
A single-center retrospective study on the clinical features of thyrotoxic periodic paralysis
Kota Yamada; Akiyo Tanabe; Makiko Hashimoto; Mitsuru Ohsugi; Kohjiro Ueki; Hiroshi Kajio
2024
In plain language
Thyrotoxic periodic paralysis presented with severe hypokalemia averaging 2.3 mEq/L, predominantly in newly diagnosed Graves' disease, requiring urgent potassium repletion and thyroid hormone suppression.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-119542
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.